P

Inventor

LOWMAN HENRY B

US63 patents
⚠️ This page may combine multiple inventors who share the name “LOWMAN HENRY B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

44 patents
US7169901B2Jan 30, 2007

Anti-VEGF antibodies

GENENTECH INC160 citations99
US7060269B1Jun 13, 2006

Anti-VEGF antibodies

GENENTECH INC342 citations99
US6884879B1Apr 26, 2005

Anti-VEGF antibodies

GENENTECH INC623 citations99
US6172213B1Jan 9, 2001

Anti-IgE antibodies and method of improving polypeptides

GENENTECH INC155 citations99
US5994511ANov 30, 1999

Anti-IgE antibodies and methods of improving polypeptides

GENENTECH INC210 citations99
US5834598ANov 10, 1998

Human growth hormone variants

GENENTECH INC108 citations99
US7375193B2May 20, 2008

Anti-VEGF antibodies

GENENTECH INC62 citations98
US7365166B2Apr 29, 2008

Anti-VEGF antibodies

GENENTECH INC90 citations98
US7297334B2Nov 20, 2007

Anti-vegf antibodies

GENENTECH INC112 citations98
US6057292AMay 2, 2000

Method for inhibiting growth hormone action

GENENTECH INC198 citations98
US5849535ADec 15, 1998

Human growth hormone variants

GENENTECH INC346 citations98
US5821047AOct 13, 1998

Monovalent phage display

GENENTECH INC1,243 citations98
US5750373AMay 12, 1998

Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants

GENENTECH INC1,868 citations98
US5688666ANov 18, 1997

Growth hormone variants with altered binding properties

GENENTECH INC154 citations98
US7799900B2Sep 21, 2010

Immunoglobulin variants and uses thereof

GENENTECH INC103 citations97
US7435797B2Oct 14, 2008

Anti-HER2 antibody variants

GENENTECH INC79 citations96
US6761889B2Jul 13, 2004

Anti-IgE antibodies

GENENTECH INC41 citations96
US6682735B2Jan 27, 2004

Anti-IgE antibodies

GENENTECH INC30 citations96
US6632926B1Oct 14, 2003

Antibody variants

GENENTECH INC159 citations96
US6290957B1Sep 18, 2001

Anti-IgE antibodies and method of improving polypeptides

GENENTECH INC44 citations96
US6251865B1Jun 26, 2001

Insulin-like growth factor agonist molecules

GENENTECH INC39 citations96
US6121416ASep 19, 2000

Insulin-like growth factor agonist molecules

GENENTECH INC38 citations96
US7850966B2Dec 14, 2010

Method of treating breast cancer using anti-HER2 antibody variants

GENENTECH INC45 citations95
US6403764B1Jun 11, 2002

Insulin-like growth factor-1 protein variants

GENENTECH INC64 citations93
US8372403B2Feb 12, 2013

Humanized anti-factor D antibodies and uses thereof

GENENTECH INC17 citations92
US7157085B2Jan 2, 2007

Method for treating IgE-mediated disorders

GENENTECH INC27 citations92
US6723833B1Apr 20, 2004

Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent

GENENTECH INC32 citations92
US6645775B1Nov 11, 2003

Insulin-like growth factor agonist molecules

GENENTECH INC17 citations92
US7608681B2Oct 27, 2009

Methods and compositions for prolonging elimination half-times of bioactive compounds

GENENTECH INC24 citations90
US6750321B1Jun 15, 2004

Insulin-like growth factor agonist molecules

GENENTECH INC30 citations90
US7432244B2Oct 7, 2008

Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides

GENENTECH INC16 citations89
US7071300B2Jul 4, 2006

IGF antagonist peptides

GENENTECH INC18 citations89
US8753826B2Jun 17, 2014

Methods of detecting factor D with anti-factor D antibodies

GENENTECH INC8 citations84
US6420518B1Jul 16, 2002

Insulin-like growth factor agonist molecules

GENENTECH INC11 citations81
US6693078B1Feb 17, 2004

Insulin-like growth factor agonist molecules

GENENTECH INC2 citations74
US6680298B1Jan 20, 2004

Insulin-like growth factor agonist molecules

GENENTECH INC2 citations74
US6635619B1Oct 21, 2003

Insulin-like growth factor agonist molecules

GENENTECH INC3 citations74
US6632794B1Oct 14, 2003

Insulin-like growth factor agonist molecules

GENENTECH INC4 citations74
US6620789B1Sep 16, 2003

Insulin-like growth factor agonist molecules

GENENTECH INC3 citations74
US6608031B1Aug 19, 2003

Insulin-like growth factor agonist molecules

GENENTECH INC3 citations74
US7101851B2Sep 5, 2006

IgE receptor antagonists

GENENTECH INC7 citations73
US6949349B1Sep 27, 2005

Insulin-like growth factor agonist molecules

GENENTECH INC0 citations63
US6716586B1Apr 6, 2004

Insulin-like growth factor agonist molecules

GENENTECH INC1 citations63
US6713451B1Mar 30, 2004

Insulin-like growth factor agonist molecules

GENENTECH INC1 citations63

AN LING-LING

3 patents

ADAMS CAMELLIA W

1 patent

LOWMAN HENRY B

1 patent

CHEN YVONNE M

1 patent

Showing the top 50 of 63 patents by PatentIndex Score.